TOMI Eyes $6.5M World Cup Crowd as Biosecurity Demand Surges
Event summary
- TOMI reports surge in demand for SteraMist iHP technology ahead of 2026 FIFA World Cup, with 6.5M attendees expected
- Healthcare facilities and stadiums upgrading sanitation protocols due to heightened awareness of contagious threats like measles
- Existing customers increasing investments in system maintenance, training, and TOMI's proprietary BIT solution
- Company positions biosecurity as emerging critical infrastructure component for public gatherings and global travel
The big picture
The 2026 FIFA World Cup is accelerating recognition of biosecurity as critical infrastructure, potentially unlocking a multi-billion-dollar market opportunity. TOMI's positioning at the intersection of emerging pathogen defense and large public gatherings places it at the forefront of this strategic shift. The company's technology, originally developed with DARPA funding, is now seeing commercial adoption at scale, suggesting a broader trend toward institutionalization of disinfection capabilities.
What we're watching
- Market Expansion
- Whether TOMI can sustain momentum beyond the World Cup into other large-scale public events and infrastructure sectors
- Government Funding
- The pace at which biosecurity becomes a funded public infrastructure priority similar to emergency response systems
- Competitive Position
- How TOMI's DARPA-backed technology differentiates it in an increasingly crowded biosecurity market
Related topics